The Gastroparesis Clinical Research Consortium  (GpCRC) is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to focus on the etiology, natural history, and therapy of gastroparesis. The goal of this consortium is to perform clinical, epidemiological, and therapeutic research in gastroparesis and provide an infrastructure that can rapidly and efficiently design and conduct clinical trials for effective medical, surgical, or other interventions to improve treatment of patients with gastroparesis.


Gastroparesis FDA Guidance


 GpCRC Continuation 2016

  • RFAs will be released in fall 2015

  • Letter of intent due Feb. 2016, Receipt date: March 2016

  • Summer review, Sept 2016 Council



Date Calculators
   Difference between 2 dates
   Add or subtract time from date



   Last updated:  01 September 2015
   2015, GpCRC, JHU, Center for Clinical Trials,  All Rights Reserved